Zydiwon Cream contains Amorolfine 0.25% w/w, a broad-spectrum antifungal agent, and Phenoxyethanol 1% w/w, a preservative with antimicrobial properties. Amorolfine acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting fungal cell growth and leading to cell death. It is primarily indicated for the topical treatment of superficial fungal infections, including dermatophytosis, onychomycosis, and candidiasis affecting the skin and nails. The inclusion of Phenoxyethanol helps maintain the formulation’s stability and prevents microbial contamination during use. Zydiwon Cream is intended for external application and should be applied to the affected area once or twice daily, as directed by a healthcare professional. Patients should ensure the area is clean and dry before application and avoid contact with eyes and mucous membranes. The cream is generally well tolerated; however, mild local irritation, redness, or itching may occur in some individuals. It is contraindicated in patients with known hypersensitivity to any of the components. Use during pregnancy and lactation should be under medical supervision. Zydiwon Cream offers an effective topical option for managing fungal infections with a favorable safety profile.